Lifecore Biomedical adopts 2026 Stock Incentive Plan pending shareholder approval
The company's board approved a new equity compensation plan effective October 16, 2026, replacing the existing plan for future awards to employees and service providers. The plan requires stockholder approval within one year and includes options for stock grants, options, SARs, and stock units.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day